CO6940375A2 - Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo - Google Patents
Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismoInfo
- Publication number
- CO6940375A2 CO6940375A2 CO13301122A CO13301122A CO6940375A2 CO 6940375 A2 CO6940375 A2 CO 6940375A2 CO 13301122 A CO13301122 A CO 13301122A CO 13301122 A CO13301122 A CO 13301122A CO 6940375 A2 CO6940375 A2 CO 6940375A2
- Authority
- CO
- Colombia
- Prior art keywords
- lysiloxidase
- homologue
- test
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Silicon Polymers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161492210P | 2011-06-01 | 2011-06-01 | |
| US201161550895P | 2011-10-24 | 2011-10-24 | |
| US201161578813P | 2011-12-21 | 2011-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6940375A2 true CO6940375A2 (es) | 2014-05-09 |
Family
ID=46208194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO13301122A CO6940375A2 (es) | 2011-06-01 | 2013-12-27 | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US20140206017A1 (enExample) |
| EP (1) | EP2714744A1 (enExample) |
| JP (3) | JP2014523521A (enExample) |
| KR (1) | KR20140048156A (enExample) |
| CN (1) | CN103946241A (enExample) |
| AP (1) | AP2013007285A0 (enExample) |
| AR (1) | AR086657A1 (enExample) |
| AU (2) | AU2012261883A1 (enExample) |
| BR (1) | BR112013030682A2 (enExample) |
| CA (1) | CA2837534A1 (enExample) |
| CL (1) | CL2013003445A1 (enExample) |
| CO (1) | CO6940375A2 (enExample) |
| CR (1) | CR20130657A (enExample) |
| EA (1) | EA201391627A1 (enExample) |
| EC (1) | ECSP13013092A (enExample) |
| IL (1) | IL229631A0 (enExample) |
| MA (1) | MA35212B1 (enExample) |
| MD (1) | MD20130098A2 (enExample) |
| MX (1) | MX2013013905A (enExample) |
| PE (1) | PE20141450A1 (enExample) |
| PH (1) | PH12013502490A1 (enExample) |
| TW (1) | TW201319572A (enExample) |
| UY (1) | UY34115A (enExample) |
| WO (1) | WO2012167181A1 (enExample) |
| ZA (1) | ZA201308812B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| CN110372795A (zh) | 2007-08-02 | 2019-10-25 | 吉利德生物制剂公司 | Lox和loxl2抑制剂及其应用 |
| WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
| RU2012110585A (ru) | 2009-08-21 | 2013-09-27 | Джилид Байолоджикс, Инк. | Каталичические домены лизилоксидазы и loxl2 |
| RU2015108348A (ru) | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения |
| SG11201503065PA (en) * | 2012-10-30 | 2015-05-28 | Gilead Sciences Inc | Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2) |
| US20150342943A1 (en) | 2014-06-03 | 2015-12-03 | Gilead Sciences, Inc. | Methods of treating liver disease |
| SG11201609522TA (en) * | 2014-06-11 | 2016-12-29 | Gilead Sciences Inc | Methods for treating cardiovascular diseases |
| MA41252A (fr) | 2014-12-23 | 2017-10-31 | Gilead Sciences Inc | Formes solides d'un inhibiteur d'ask 1 |
| CA3016081A1 (en) | 2016-03-04 | 2017-09-08 | Gilead Sciences, Inc. | Compositions and combinations of autotaxin inhibitors |
| JP2019513737A (ja) | 2016-04-08 | 2019-05-30 | ギリアード サイエンシーズ， インコーポレイテッド | がん、炎症性疾患および自己免疫疾患を処置するための組成物および方法 |
| GB201704206D0 (en) | 2017-03-16 | 2017-05-03 | Nordic Bioscience As | Lysyl oxidase like-2 assay |
| WO2023091479A1 (en) * | 2021-11-17 | 2023-05-25 | AmMax Bio, Inc. | Detection and treatment of idiopathic pulmonary fibrosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6352862B1 (en) * | 1989-02-17 | 2002-03-05 | Unilever Patent Holdings B.V. | Analytical test device for imuno assays and methods of using same |
| FI92882C (fi) * | 1992-12-29 | 1995-01-10 | Medix Biochemica Ab Oy | Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi |
| US20030114410A1 (en) * | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
| CN110372795A (zh) * | 2007-08-02 | 2019-10-25 | 吉利德生物制剂公司 | Lox和loxl2抑制剂及其应用 |
| JP2010038735A (ja) * | 2008-08-05 | 2010-02-18 | Terumo Corp | 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙 |
| BR112012008080A2 (pt) * | 2009-08-21 | 2017-07-04 | Gilead Biologics Inc | ensaios de rastreamento in vivo. |
| RU2015108348A (ru) * | 2010-02-04 | 2015-07-20 | Джилид Байолоджикс, Инк. | Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения |
| US9556882B2 (en) * | 2011-05-10 | 2017-01-31 | Borgwarner Inc. | Turbocharger with variable turbine geometry |
-
2012
- 2012-06-01 US US14/122,984 patent/US20140206017A1/en not_active Abandoned
- 2012-06-01 US US13/487,109 patent/US20120309020A1/en not_active Abandoned
- 2012-06-01 MX MX2013013905A patent/MX2013013905A/es not_active Application Discontinuation
- 2012-06-01 WO PCT/US2012/040585 patent/WO2012167181A1/en not_active Ceased
- 2012-06-01 AP AP2013007285A patent/AP2013007285A0/xx unknown
- 2012-06-01 EA EA201391627A patent/EA201391627A1/ru unknown
- 2012-06-01 BR BR112013030682A patent/BR112013030682A2/pt not_active IP Right Cessation
- 2012-06-01 CN CN201280037235.7A patent/CN103946241A/zh active Pending
- 2012-06-01 JP JP2014513770A patent/JP2014523521A/ja not_active Withdrawn
- 2012-06-01 UY UY0001034115A patent/UY34115A/es not_active Application Discontinuation
- 2012-06-01 MD MDA20130098A patent/MD20130098A2/ro not_active Application Discontinuation
- 2012-06-01 PE PE2013002739A patent/PE20141450A1/es not_active Application Discontinuation
- 2012-06-01 TW TW101119847A patent/TW201319572A/zh unknown
- 2012-06-01 KR KR1020137034711A patent/KR20140048156A/ko not_active Withdrawn
- 2012-06-01 CA CA2837534A patent/CA2837534A1/en not_active Abandoned
- 2012-06-01 AU AU2012261883A patent/AU2012261883A1/en not_active Abandoned
- 2012-06-01 EP EP12725601.4A patent/EP2714744A1/en not_active Withdrawn
- 2012-06-01 PH PH1/2013/502490A patent/PH12013502490A1/en unknown
- 2012-06-01 AR ARP120101959A patent/AR086657A1/es unknown
-
2013
- 2013-11-25 ZA ZA2013/08812A patent/ZA201308812B/en unknown
- 2013-11-26 IL IL229631A patent/IL229631A0/en unknown
- 2013-11-29 CL CL2013003445A patent/CL2013003445A1/es unknown
- 2013-12-13 CR CR20130657A patent/CR20130657A/es unknown
- 2013-12-19 EC ECSP13013092 patent/ECSP13013092A/es unknown
- 2013-12-27 CO CO13301122A patent/CO6940375A2/es unknown
- 2013-12-30 MA MA36627A patent/MA35212B1/fr unknown
-
2016
- 2016-06-09 JP JP2016115175A patent/JP2016164578A/ja active Pending
- 2016-10-12 AU AU2016244254A patent/AU2016244254B2/en not_active Ceased
- 2016-12-01 US US15/366,986 patent/US20170269085A1/en not_active Abandoned
-
2017
- 2017-11-16 JP JP2017221000A patent/JP2018049033A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| UY34115A (es) | 2013-01-03 |
| CL2013003445A1 (es) | 2014-07-25 |
| PE20141450A1 (es) | 2014-11-06 |
| KR20140048156A (ko) | 2014-04-23 |
| ZA201308812B (en) | 2014-08-27 |
| US20170269085A1 (en) | 2017-09-21 |
| EP2714744A1 (en) | 2014-04-09 |
| WO2012167181A1 (en) | 2012-12-06 |
| ECSP13013092A (es) | 2014-08-29 |
| MA35212B1 (fr) | 2014-06-02 |
| TW201319572A (zh) | 2013-05-16 |
| CN103946241A (zh) | 2014-07-23 |
| AU2016244254A1 (en) | 2016-11-03 |
| CR20130657A (es) | 2014-05-16 |
| JP2018049033A (ja) | 2018-03-29 |
| MX2013013905A (es) | 2014-05-14 |
| NZ618682A (en) | 2016-04-29 |
| BR112013030682A2 (pt) | 2016-12-06 |
| AU2016244254B2 (en) | 2018-10-18 |
| AR086657A1 (es) | 2014-01-15 |
| AP2013007285A0 (en) | 2013-11-30 |
| JP2014523521A (ja) | 2014-09-11 |
| AU2012261883A1 (en) | 2013-05-02 |
| IL229631A0 (en) | 2014-01-30 |
| US20140206017A1 (en) | 2014-07-24 |
| PH12013502490A1 (en) | 2014-01-20 |
| CA2837534A1 (en) | 2012-12-06 |
| MD20130098A2 (ro) | 2014-06-30 |
| EA201391627A1 (ru) | 2014-08-29 |
| US20120309020A1 (en) | 2012-12-06 |
| JP2016164578A (ja) | 2016-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6940375A2 (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
| IL235401A0 (en) | St2l antagonists and methods of use | |
| CO6801741A2 (es) | Derivados c4-monometil triterpenoides y sus métodos de uso | |
| CO7000747A2 (es) | Anticuerpos anti-lrp5 y métodos de uso | |
| CL2014002086A1 (es) | Anticuerpos cd47 y métodos de uso los mismos | |
| CO7020870A2 (es) | Anticuerpos anti-htra1 y métodos de uso | |
| CL2015000640A1 (es) | Variantes de hppd y métodos de uso | |
| CO6870033A2 (es) | Compuestos terapéuticos y métodos de uso relacionados | |
| BR112014028366A2 (pt) | anticorpos anti-ly6e e imunoconjugados e métodos de uso | |
| CR20150380A (es) | Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico | |
| CO6862148A2 (es) | Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas | |
| HRP20180126T1 (hr) | Pripravci pcsk9 irna i postupci njihove upotrebe | |
| CO6870005A2 (es) | Composición anti-cgrp y uso de las mismas | |
| CO7030962A2 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
| CO7010834A2 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
| BR112014012590A2 (pt) | anticorpos anti-cd98 e métodos de uso dos mesmos | |
| CL2015001266A1 (es) | Anticuerpos de antihemaglutinina y métodos de uso. | |
| BR112014002716A2 (pt) | anticorpos anti-poliubiquitina e métodos de uso | |
| HRP20171579T8 (hr) | Antigljivična sredstva i njihova upotreba | |
| PL2903754T3 (pl) | Łyżka i jej zastosowanie | |
| BR112014000329A2 (pt) | método de análise de distúrbios cardiovasculares e uso do mesmo | |
| BR112014000049A2 (pt) | pirrolotriazinas substituídas com hidroximelilarilo e sua utilização | |
| BR112013022552A2 (pt) | compostos de quinazolina substituídos com alcino e métodos de uso | |
| EP2937687A4 (en) | sample injector | |
| SMT201600069B (it) | Composizioni comprendenti 15-hepe e metodi d’uso delle stesse |